Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide (Q28274564)

Clinical Pharmacokinetics

Europe PubMed Central

title

Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide (English)

0 references

1 reference

M Mayersohn

1

0 references

T W Guentert

series ordinal

2

0 references

language of work or name

English

0 references

publication date

November 1995

0 references

published in

0 references

volume

29

0 references

page(s)

292-332

0 references

issue

5

0 references

exact match

https://scigraph.springernature.com/pub.10.2165/00003088-199529050-00002

0 references

cites work

Assignment of genes for human monoamine oxidases A and B to the X chromosome

1 reference

12 December 2020

Biochemical effects of high single doses of moclobemide in man: correlation with plasma concentrations

1 reference

12 December 2020

The new generation of monoamine oxidase inhibitors

1 reference

12 December 2020

An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of MAO A and B.

1 reference

12 December 2020

Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine

1 reference

12 December 2020

Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group

1 reference

12 December 2020

Interaction studies with moclobemide

1 reference

12 December 2020

Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers

1 reference

12 December 2020

Influence of moclobemide on ibuprofen-induced faecal blood loss

1 reference

12 December 2020

Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers

1 reference

12 December 2020

The reaction of phenylhydrazine with microsomal cytochrome P-450. Catalysis of heme modification

1 reference

12 December 2020

Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor

1 reference

12 December 2020

Monoamine oxidase, hydrogen peroxide, and Parkinson's disease.

1 reference

12 December 2020

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

12 December 2020

Disposition kinetics of moclobemide, a new MAO-A inhibitor, in subjects with impaired renal function

1 reference

12 December 2020

Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors

1 reference

12 December 2020

Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.

1 reference

12 December 2020

On tyramine, food, beverages and the reversible MAO inhibitor moclobemide

1 reference

12 December 2020

Efficacy and adverse effects of moclobemide

1 reference

12 December 2020

Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor

1 reference

12 December 2020

Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

1 reference

12 December 2020

Subarachnoid Hemorrhage Following Ephedrine and MAO Inhibitor

1 reference

12 December 2020

Evidence found for a possible 'aggression gene'

1 reference

12 December 2020

Further studies on iproniazid phosphate; isonicotinil-isopropyl-hydrazine phosphate marsilid

1 reference

12 December 2020

Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.

1 reference

12 December 2020

Inhibitory effect of tranylcypromine on hepatic drug metabolism in the rat

1 reference

12 December 2020

Biochemistry and genetics of monoamine oxidase

1 reference

12 December 2020

The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies

1 reference

12 December 2020

Differential response patterns to MAO inhibitors and tricyclics.

1 reference

12 December 2020

Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.

1 reference

12 December 2020

Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients

1 reference

12 December 2020

Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain).

1 reference

12 December 2020

MAOIs and hypertensive crises: the role of OTC drugs

1 reference

12 December 2020

Processes Regulating the Functional Activity of Brain 5-Hydroxytryptamine: Results of Animal Experimentation and Their Relevance to the Understanding and Treatment of Depression

1 reference

12 December 2020

Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics

1 reference

12 December 2020

Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.

1 reference

12 December 2020

Relationship between the terminal disposition half-life and mean residence time in multicompartment models

1 reference

12 December 2020

Turnover of monoamine oxidase B (MAO-B) in pig brain by positron emission tomography using 11C-L-deprenyl

1 reference

12 December 2020

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

1 reference

12 December 2020

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

1 reference

12 December 2020

HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS

1 reference

12 December 2020

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites

1 reference

12 December 2020

Commentary: a physiological approach to hepatic drug clearance

1 reference

12 December 2020

Promoter organization and activity of human monoamine oxidase (MAO) A and B genes

1 reference

12 December 2020

Inhibition of cytochrome P-450-dependent oxidation reactions by MAO inhibitors in rat liver microsomes

1 reference

12 December 2020

Effect of food intake on the relative bioavailability of moclobemide (Ro 11-1163).

1 reference

12 December 2020

The present status of monoamine oxidase inhibitors

1 reference

12 December 2020

Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic amines

1 reference

12 December 2020

Comparison of the pharmacokinetics of moclobemide in poor and efficient metabolizers of debrisoquine

1 reference

12 December 2020

Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man

1 reference

12 December 2020

Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Interactions of monoamine oxidase with substrates and inhibitors

1 reference

12 December 2020

Expression of monoamine oxidase B activity in astrocytes of senile plaques.

1 reference

12 December 2020

Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers

1 reference

12 December 2020

Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450

1 reference

12 December 2020

Pharmacokinetic and metabolic aspects of the moclobemide-food interaction

1 reference

12 December 2020

Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction

1 reference

12 December 2020

Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

The interactions of hydrazine derivatives with rat-hepatic cytochrome P-450

1 reference

12 December 2020

Depression and Parkinson's disease: a review

1 reference

12 December 2020

The catalytic behaviour of monoamine oxidase

1 reference

12 December 2020

Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.

1 reference

12 December 2020

Plasma 3,4-dihydroxyphenylglycol as a tool to assess the role of neuronal uptake in the anaesthetized rabbit.

1 reference

12 December 2020

Post-infarction depression

1 reference

12 December 2020

5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment

1 reference

12 December 2020

Clinical pharmacology of reversible MAO-A inhibitors

1 reference

12 December 2020

A review of the pharmacology of selegiline

1 reference

12 December 2020

New directions in monoamine oxidase A and B selective inhibitors and substrates

1 reference

12 December 2020

Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo

1 reference

12 December 2020

MAO Inhibitors in Psychiatric Therapy: Effects and Side Effects

1 reference

12 December 2020

Tyramine content of preserved and fermented foods or condiments of Far Eastern cuisine

1 reference

12 December 2020

Effects of Dopamine in Man

1 reference

12 December 2020

Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers

1 reference

12 December 2020

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

1 reference

12 December 2020

Moclobemide excretion in human breast milk

1 reference

12 December 2020

Cimetidine alters the disposition kinetics of the monoamine oxidase-A inhibitor moclobemide

1 reference

12 December 2020

An update of recent moclobemide interaction data

1 reference

12 December 2020

Clinical experience with iproniazid (marsilid)

1 reference

12 December 2020

Monoamine oxidase inhibitors and L-dopa

1 reference

12 December 2020

Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function

1 reference

12 December 2020

The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease

1 reference

12 December 2020

Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjects

1 reference

12 December 2020

Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure.

1 reference

12 December 2020

Estimation of variance for harmonic mean half-lives.

1 reference

12 December 2020

Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs

1 reference

12 December 2020

Biotransformation of moclobemide in humans

1 reference

12 December 2020

Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment

1 reference

12 December 2020

Monoamine oxidase inhibitor interactions with other drugs.

1 reference

12 December 2020

X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism

1 reference

12 December 2020

Monoamine oxidase, brain ageing and degenerative diseases

1 reference

12 December 2020

Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease--a hypothesis

1 reference

12 December 2020